Levocetirizina Zentiva

Levocetirizine Dihydrochloride, the active ingredient in Levocetirizina Zentiva, is an antihistamine presented as an oral formulation for oral use. It is indicated for the relief of symptoms such as nasal congestion, sneezing, itching and watery eyes in allergic rhinitis, and for reducing hives and itching in chronic idiopathic urticaria in adults and adolescents. GNH USA supplies Levocetirizina Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Levocetirizine Dihydrochloride is an antihistamine that acts on peripheral H1 receptors to control allergic conditions. - Allergic rhinitis: Reduces nasal congestion, sneezing, itching and watery eyes associated with seasonal or perennial allergies. - Chronic idiopathic urticaria: Decreases frequency and severity of hives and associated itching. - Allergic conjunctivitis: Alleviates eye itching, redness and tearing caused by histamine release.

Levocetirizine Dihydrochloride may cause a range of adverse reactions, most of which are mild and transient. Common Side Effects: - Headache: mild to moderate headache. - Dry mouth: sensation of oral dryness. - Drowsiness: mild somnolence, especially at initiation. - Fatigue: feeling of tiredness. Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes.

Before prescribing Levocetirizine Dihydrochloride, clinicians should consider several precautionary measures. - Renal impairment: dose adjustment may be required in patients with reduced kidney function. - Elderly patients: monitor for increased sedation or confusion. - Pregnancy and lactation: use only if potential benefit outweighs risk. - Concomitant CNS depressants: avoid additive drowsiness. - Driving and machinery: caution advised if somnolence occurs. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Levocetirizine Dihydrochloride can interact with other medicines, altering its efficacy or safety profile. Major Interactions (Avoid): - Ketoconazole: strong CYP3A4 inhibitors may increase levocetirizine plasma levels. - Ritonavir: potent CYP3A4 inhibition can raise drug concentration, risking toxicity. Moderate Interactions (Monitor Closely): - Alcohol: may enhance drowsiness. - Other antihistamines: additive sedation. - Theophylline: may reduce antihistaminic effect.